{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:30:45Z","timestamp":1715988645602},"reference-count":22,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"unspecified","delay-in-days":5219,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. psychiatr."],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim is to investigate the association between apolipoprotein E (ApoE) and panic disorder (PD). Genotyping 92 PD patients [Diagnostic Statistic Manual IV (DSM IV) criteria] and 174 controls no differences were found between both groups. Variation in the ApoE-gene was not associated with the development of PD.<\/jats:p>","DOI":"10.1016\/j.eurpsy.2005.04.012","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T11:43:59Z","timestamp":1118835839000},"page":"59-61","source":"Crossref","is-referenced-by-count":5,"title":["Negative evidences in association between apolipoprotein E polymorphism and panic disorder"],"prefix":"10.1017","volume":"21","author":[{"given":"S.","family":"Mart\u00ednez-Barrondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"S\u00e1iz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Garc\u00eda-Portilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Coto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Bascar\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bouso\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bobes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"S0924933800239813_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1176\/ajp.150.3.527c","article-title":"High cholesterol levels in patients with panic disorder","volume":"150","author":"Feder","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"S0924933800239813_bib12","doi-asserted-by":"publisher","DOI":"10.1385\/JMN:20:3:395"},{"key":"S0924933800239813_bib18","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(90)90024-V"},{"key":"S0924933800239813_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/ajp.149.3.376","article-title":"High cholesterol levels in patients with panic disorder","volume":"149","author":"Bajwa","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"S0924933800239813_bib22","unstructured":"[22] World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subject. Amended by 41st World Medical Assembly, Hong Kong, 1989."},{"key":"S0924933800239813_bib2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00309-5"},{"key":"S0924933800239813_bib21","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92823-K"},{"key":"S0924933800239813_bib10","first-page":"127","article-title":"Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol","volume":"28","author":"Morrow","year":"2003","journal-title":"J. Psychiatry Neurosci."},{"key":"S0924933800239813_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0447.2002.10488.x","article-title":"Apolipoprotein E genotype and schizophrenia: further negative evidence","volume":"105","author":"S\u00e1iz","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"S0924933800239813_bib1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00194-8"},{"key":"S0924933800239813_bib13","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system","volume":"262","author":"Pitas","year":"1987","journal-title":"J. Biol. Chem."},{"key":"S0924933800239813_bib14","doi-asserted-by":"publisher","DOI":"10.1038\/nn0403-345"},{"key":"S0924933800239813_bib20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205147200"},{"key":"S0924933800239813_bib9","doi-asserted-by":"publisher","DOI":"10.1385\/MN:27:1:1"},{"key":"S0924933800239813_bib4","first-page":"24","article-title":"Lipoproteins and lipid peroxidation in Alzheimer's disease","volume":"7","author":"Bassett","year":"2003","journal-title":"J. Nutr. Health Aging"},{"key":"S0924933800239813_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1176\/ajp.146.7.917","article-title":"Plasma lipid levels in patients with panic disorder or agoraphobia","volume":"146","author":"Hayward","year":"1989","journal-title":"Am. J. Psychiatry"},{"key":"S0924933800239813_bib8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.3.566"},{"key":"S0924933800239813_bib11","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(03)00099-3"},{"key":"S0924933800239813_bib16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.1998.tb02707.x"},{"key":"S0924933800239813_bib17","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00106-8"},{"key":"S0924933800239813_bib19","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2000.0028"},{"key":"S0924933800239813_bib5","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4927(96)03003-X"}],"container-title":["European Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933805000970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933805000970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924933800239813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T22:05:40Z","timestamp":1626041140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924933800239813\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0924933800239813"],"URL":"https:\/\/doi.org\/10.1016\/j.eurpsy.2005.04.012","relation":{},"ISSN":["0924-9338","1778-3585"],"issn-type":[{"value":"0924-9338","type":"print"},{"value":"1778-3585","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}